Healthcare Health/Fitness

Amgen Scraps Experimental Weight Loss Pill, Moves Forward With Injectable Drug in Development for Obesity

Amgen will discontinue its experimental weight loss pill and focus on developing injectable drugs and other obesity-related products.


USDA Recalls 16,000 Pounds of Walmart Ground Beef Over E. coli Contamination

The USDA announced a nationwide recall of over 16,000 pounds of ground beef sold at Walmart due to potential E. coli contamination. The beef originated from Cargill Meat Solutions in Hazleton, Pennsyl..

Peloton CEO Barry McCarthy to Step Down While the Company Faces a Series of Layoffs Due to Low Profits

Peloton undergoes leadership change with CEO Barry McCarthy stepping down, accompanied by layoffs of 15% of staff, following disappointing fiscal third-quarter results...

Novo Nordisk's Q1 Profit Surges 28%, Thanks To Booming Demand for Weight Loss Drugs

Novo Nordisk exceeded profit expectations in Q1 2024 with a 28% surge in net profit, driven by Wegovy's success...


Latest News

U.S. startups get OK for smartphone-based heart tracking
For a growing U.S. aging population, tracking heart health via a smartphone can mean the difference between life and death. This week, two Silicon Valley startups received a green-light from the U.S.
Johnson & Johnson to seek buyer for medical device maker unit
Johnson & Johnson (JNJ.N) plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.
IBM launches Watson system for research, hopes for breakthroughs
International Business Machines Corp on Wednesday launched a computer system that can quickly identify patterns in massive amounts of data, an ability that IBM said should hasten breakthroughs in scie
Facing shareholder demands, Allergan calls special meeting for December 18
Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals
U.S. approval of Merck cancer immunotherapy expected soon
U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources
Roche to buy U.S. biotech firm InterMune for $8.3 billion
Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.
Apps put fitness fans through short, sharp workouts
Fitness buffs who can't make it to the gym but still want to exercise can turn to apps for a short, intense workout when they are pressed for time. The U.S. Centers for Disease Control recommend that
Community Health says data stolen in cyber attack from China
Community Health Systems Inc (CYH.N), one of the biggest U.S. hospital groups, said on Monday it was the victim of a cyber attack from China, resulting in the theft of Social Security numbers and othe
Now Fully Financed, Okyanos Is Poised To Start Mending Broken Hearts
Following its $8.9 million Series B capital raise in March, Okyanos Heart Institute is rapidly approaching the day when it will be able to treat the first heart patient using autologous adipose derive
Powerade settles score with Gatorade over LeBron James cramps; market share up
Powerade on Monday gets even with Gatorade over the latter's taunting of LeBron James in Game 1 of the NBA Finals. Miami Heat's superstar and Powerade endorser James suffered from severe leg cramps tw
Real Time Analytics